These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
550 related articles for article (PubMed ID: 28462384)
1. TRIF Differentially Regulates Hepatic Steatosis and Inflammation/Fibrosis in Mice. Yang L; Miura K; Zhang B; Matsushita H; Yang YM; Liang S; Song J; Roh YS; Seki E Cell Mol Gastroenterol Hepatol; 2017 May; 3(3):469-483. PubMed ID: 28462384 [TBL] [Abstract][Full Text] [Related]
2. Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet. Ibusuki R; Uto H; Arima S; Mawatari S; Setoguchi Y; Iwashita Y; Hashimoto S; Maeda T; Tanoue S; Kanmura S; Oketani M; Ido A; Tsubouchi H Liver Int; 2013 Nov; 33(10):1549-56. PubMed ID: 23682724 [TBL] [Abstract][Full Text] [Related]
3. Exogenous Administration of Low-Dose Lipopolysaccharide Potentiates Liver Fibrosis in a Choline-Deficient l-Amino-Acid-Defined Diet-Induced Murine Steatohepatitis Model. Nakanishi K; Kaji K; Kitade M; Kubo T; Furukawa M; Saikawa S; Shimozato N; Sato S; Seki K; Kawaratani H; Moriya K; Namisaki T; Yoshiji H Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31163617 [TBL] [Abstract][Full Text] [Related]
4. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells. Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887 [TBL] [Abstract][Full Text] [Related]
5. Interventional Potential of Recombinant Feline Hepatocyte Growth Factor in a Mouse Model of Non-alcoholic Steatohepatitis. Yang YM; Fukui M; Wang Z; Miao F; Karriker MJ; Seki E Front Endocrinol (Lausanne); 2018; 9():378. PubMed ID: 30083132 [No Abstract] [Full Text] [Related]
7. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis. Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of hyaluronan synthesis by 4-methylumbelliferone ameliorates non-alcoholic steatohepatitis in choline-deficient L-amino acid-defined diet-induced murine model. Yang YM; Wang Z; Matsuda M; Seki E Arch Pharm Res; 2021 Feb; 44(2):230-240. PubMed ID: 33486695 [TBL] [Abstract][Full Text] [Related]
9. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling. Li SW; Takahara T; Que W; Fujino M; Guo WZ; Hirano SI; Ye LP; Li XK Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G450-G463. PubMed ID: 33439102 [TBL] [Abstract][Full Text] [Related]
10. Hepatocyte Toll-Like Receptor 5 Promotes Bacterial Clearance and Protects Mice Against High-Fat Diet-Induced Liver Disease. Etienne-Mesmin L; Vijay-Kumar M; Gewirtz AT; Chassaing B Cell Mol Gastroenterol Hepatol; 2016 Sep; 2(5):584-604. PubMed ID: 28090564 [TBL] [Abstract][Full Text] [Related]
11. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Yamaguchi K; Yang L; McCall S; Huang J; Yu XX; Pandey SK; Bhanot S; Monia BP; Li YX; Diehl AM Hepatology; 2007 Jun; 45(6):1366-74. PubMed ID: 17476695 [TBL] [Abstract][Full Text] [Related]
12. Macrophage-derived thrombospondin 1 promotes obesity-associated non-alcoholic fatty liver disease. Gwag T; Reddy Mooli RG; Li D; Lee S; Lee EY; Wang S JHEP Rep; 2021 Feb; 3(1):100193. PubMed ID: 33294831 [TBL] [Abstract][Full Text] [Related]
13. Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice. Luo X; Li H; Ma L; Zhou J; Guo X; Woo SL; Pei Y; Knight LR; Deveau M; Chen Y; Qian X; Xiao X; Li Q; Chen X; Huo Y; McDaniel K; Francis H; Glaser S; Meng F; Alpini G; Wu C Gastroenterology; 2018 Dec; 155(6):1971-1984.e4. PubMed ID: 30213555 [TBL] [Abstract][Full Text] [Related]
14. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice. Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105 [TBL] [Abstract][Full Text] [Related]
15. Protective and Detrimental Roles of p38α Mitogen-Activated Protein Kinase in Different Stages of Nonalcoholic Fatty Liver Disease. Hwang S; Wang X; Rodrigues RM; Ma J; He Y; Seo W; Park SH; Kim SJ; Feng D; Gao B Hepatology; 2020 Sep; 72(3):873-891. PubMed ID: 32463484 [TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1beta in mice. Miura K; Kodama Y; Inokuchi S; Schnabl B; Aoyama T; Ohnishi H; Olefsky JM; Brenner DA; Seki E Gastroenterology; 2010 Jul; 139(1):323-34.e7. PubMed ID: 20347818 [TBL] [Abstract][Full Text] [Related]
17. Hepatic vagus nerve regulates Kupffer cell activation via α7 nicotinic acetylcholine receptor in nonalcoholic steatohepatitis. Nishio T; Taura K; Iwaisako K; Koyama Y; Tanabe K; Yamamoto G; Okuda Y; Ikeno Y; Yoshino K; Kasai Y; Okuno M; Seo S; Sakurai T; Asagiri M; Hatano E; Uemoto S J Gastroenterol; 2017 Aug; 52(8):965-976. PubMed ID: 28044208 [TBL] [Abstract][Full Text] [Related]
18. Green tea extract protects against hepatic NFκB activation along the gut-liver axis in diet-induced obese mice with nonalcoholic steatohepatitis by reducing endotoxin and TLR4/MyD88 signaling. Li J; Sasaki GY; Dey P; Chitchumroonchokchai C; Labyk AN; McDonald JD; Kim JB; Bruno RS J Nutr Biochem; 2018 Mar; 53():58-65. PubMed ID: 29190550 [TBL] [Abstract][Full Text] [Related]
19. Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis. Widjaja AA; Singh BK; Adami E; Viswanathan S; Dong J; D'Agostino GA; Ng B; Lim WW; Tan J; Paleja BS; Tripathi M; Lim SY; Shekeran SG; Chothani SP; Rabes A; Sombetzki M; Bruinstroop E; Min LP; Sinha RA; Albani S; Yen PM; Schafer S; Cook SA Gastroenterology; 2019 Sep; 157(3):777-792.e14. PubMed ID: 31078624 [TBL] [Abstract][Full Text] [Related]